Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can online therapy plus In-Person sessions help personality disorders?

NCT ID NCT06471010

Symptom relief Sponsor: De Viersprong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new type of therapy called Blended Dynamic Interpersonal Therapy (B-DIT) for adults with personality disorders. The therapy mixes face-to-face sessions with online modules over several months. The goal is to see if this approach is acceptable to patients and therapists, and whether it helps reduce symptoms and improve functioning. Only 27 people are taking part, so this is an early look at whether the idea works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blended Dynamic Interpersonal Therapy (B-DIT) - a combination of face-to-face therapy sessions and online modules
What this could lead to
If it works, this could offer a more accessible and cost-effective treatment option for people with personality disorders, potentially improving symptoms and daily functioning.
What could go wrong
This is a very small early feasibility study with only 27 participants, so results may not apply to everyone. The therapy is new and unproven, and dropout rates could be high.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 27 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Clients referred to De Viersprong are eligible for B-DIT when they exhibit mild to moderately severe impairments in personality functioning (including both cluster B, C, or a mixed presentation within unspecified personality disorder). Clients typically present with persistent problems in specific areas of their functioning, and typically have had previous, unsuccessful treatments. Adequate functioning in at least one domain of life (such as family, work, other societal roles) should be ensured, which allows for the generalization of treatment gains during and after the relatively short-term/ low intensity intervention. All patients that are referred to B-DIT at de Viersprong are eligible for the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for treatment referral: 1. 18 years of age or older 2. mild to moderately severe impairments in personality functioning, including both cluster B and cluster C personality problems as well as a mixed presentation within unspecified personality disorder. General exclusion criteria for treatment at the Viersprong: 1. insufficient proficiency in the Dutch language 2. no permanent place of residence 3. intellectual disability (IQ \< 80) 4. organic brain disorder 5. autism spectrum disorders 6. schizophrenia or schizophreniform disorder 7. (untreated) eating disorder, extreme obesity, or a BMI \< 17.5 8. (untreated) addiction. Additional exclusion criteria for the B-DIT treatment: 1. acute risk of crisis requiring stabilizing/crisis interventions 2. Severe PTSD or the severe range of personality problems (structural: low-level borderline organization). There are no additional inclusion/exclusion criteria for participation in the study, other than those that apply to treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Personality disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

personality disorder Personality Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Personality disorders

Contacts and locations

Locations

  • De Viersprong

    Halsteren, North Brabant, 4660AA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.